WAM
HAE icon

Wolverine Asset Management’s Haemonetics HAE Stock Holding History

Wolverine Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-671
Closed -$43.1K – 1755
2026
Q1 		$37.8K Buy
+671
New +$43.7K ﹤0.01% 1298
2025
Q4 		– Sell
-2,700
Closed -$181K – 1751
2025
Q3 		$132K Buy
+2,700
New +$167K ﹤0.01% 1069
2025
Q2 		– Sell
-52
Closed -$3.44K – 1682
2025
Q1 		$3.3K Buy
+52
New +$3.54K ﹤0.01% 1402
2024
Q3 		– Sell
-17,250
Closed -$1.43M – 1703
2024
Q2 		$1.43M Buy
+17,250
New +$1.52M 0.02% 578
2021
Q4 		– Sell
-4,897
Closed -$345K – 2114
2021
Q3 		$345K Sell
4,897
-3,937
-45% -$248K ﹤0.01% 1058
2021
Q2 		$588K Buy
+8,834
New +$625K ﹤0.01% 837

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Asset Management's HAE Position: Q2 2026 in Review

Wolverine Asset Management sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 671 shares — an estimated $43.1K sold.

Wolverine Asset Management first reported a position in HAE in Q2 2021 and held it in 6 quarters. The position peaked at $1.43M in Q2 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Wolverine Asset Management reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 671 Haemonetics shares in Q2 2026, an estimated $43.1K.
  • Wolverine Asset Management first reported a position in Haemonetics in Q2 2021 and held it in 6 quarters.
  • Wolverine Asset Management's Haemonetics position peaked at $1.43M in Q2 2024.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.